⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbon Monoxide SCHEMBL863533 | 1.00 | — | — | |
| Carbon Monoxide SCHEMBL2417517 | 0.97 | — | — | |
| SCHEMBL820172 | 0.92 | — | — | |
| SCHEMBL4480097 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL597368 | 0.89 | — | — | |
| SCHEMBL9579650 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL221973 | 0.89 | — | — | |
| Ethane SCHEMBL9168230 | 0.89 | — | — | |
| SCHEMBL8559679 | 0.89 | — | — | |
| Fluoride SCHEMBL863576 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1631288-A1 | POSITIVE MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | AstraZeneca AB (SE) | 2006-03-08 | — | — | EP | claimed |
| WO-2004098600-A1 | POSITIVE MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | ASTRAZENECA AB (SE) | 2004-11-18 | — | — | WO | claimed |
| EP-2754654-B1 | METHOD FOR PRODUCING COUMARIN DERIVATIVE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-9133174-B2 | Method for producing coumarin derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-09-15 | — | — | US | disclosed |
| US-20140213786-A1 | Method for Producing Coumarin Derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2014-07-31 | — | — | US | disclosed |
| US-7018993-B2 | Antiandrogenic agent | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2006-03-28 | — | — | US | disclosed |
| EP-1631288-A1 | POSITIVE MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | AstraZeneca AB (SE) | 2006-03-08 | — | — | EP | disclosed |
| US-20050009797-A1 | Androstane derivative having substituent in 7- abd 17--positions | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-01-13 | — | — | US | disclosed |
| WO-2004098600-A1 | POSITIVE MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | ASTRAZENECA AB (SE) | 2004-11-18 | — | — | WO | disclosed |
| US-20030158164-A1 | Novel antiandrogenic agent | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-08-21 | — | — | US | disclosed |
| EP-1304334-A1 | NOVEL ANTIANDROGENIC AGENT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-04-23 | — | — | EP | disclosed |
| EP-1219631-A1 | ANTIANDROGEN AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-07-03 | — | — | EP | disclosed |